Page | |||||||
---|---|---|---|---|---|---|---|
Name and Title | Number of Shares | Consideration | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scott D. Dorfman, Chairman, President and Chief Executive Officer | 5,489,462 | $ | 45,013,588 | |||||||||
Robert J. Toner, Senior Vice President and Chief Operating Officer | 17,519 | $ | 143,656 | |||||||||
Larry C. Hanger, Senior Vice President — Client Services | 17,445 | $ | 143,049 | |||||||||
Bruce V. Benator, Director | 1,000 | $ | 8,200 | |||||||||
Joel E. Marks, Director | 30,000 | $ | 246,000 |
Restricted Stock | Stock Options | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Name and Title | Number | Consideration | Number | Consideration | ||||||||||||||||||
Scott D. Dorfman, Chairman, President and Chief Executive Officer | 350,000 | $ | 2,870,000 | — | — | |||||||||||||||||
Robert J. Toner, Senior Vice President and Chief Operating Officer | 213,652 | $ | 1,751,945 | 50,000 | $ | 182,000 | ||||||||||||||||
Larry C. Hanger, Senior Vice President — Client Services | 158,652 | $ | 1,300,946 | 50,000 | $ | 182,000 | ||||||||||||||||
Christine A. Herren, Senior Director and Corporate Controller | — | — | 40,000 | $ | 171,700 | |||||||||||||||||
Bruce V. Benator, Director | 45,000 | $ | 369,000 | 30,000 | $ | 118,300 | ||||||||||||||||
James W. Childs, Director | 20,000 | $ | 164,000 | — | — | |||||||||||||||||
Thomas J. Marano, Director | 45,000 | $ | 369,000 | 30,000 | $ | 118,300 | ||||||||||||||||
Joel E. Marks, Director | 45,000 | $ | 369,000 | 30,000 | $ | 118,300 |
Name | Cash | Equity | Pension/ NQDC | Perquisites/ Benefits | Tax Reimbursement | Other | Total | ||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Scott D. Dorfman | — | $ | 2,870,000 | — | — | — | — | $ | 2,870,000 | ||||||||||||||||||||||||||||
Robert J. Toner | — | $ | 1,933,945 | — | — | — | — | $ | 1,933,945 | ||||||||||||||||||||||||||||
Larry C. Hanger | — | $ | 1,482,946 | — | — | — | — | $ | 1,482,946 |
Selected Companies Median | |||||||
---|---|---|---|---|---|---|---|
Enterprise Value to EBITDA: | |||||||
E-commerce Focused Fulfillment Providers | 12.1x | ||||||
Broader Third-Party Logistics Companies | 10.6x | ||||||
Median of Selected Comparables | 10.8x |
Low Selected Transactions | Median Selected Transactions | High Selected Transactions | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Enterprise Value to: | |||||||||||||||||
LTM EBITDA | 5.8x | 7.8x | 12.4x |
Premium | 1-Day Prior | 30-Day Prior | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
80.0% + | 6.3 | % | 12.5 | % | ||||||||
70.0% – 80.0% | 0.0 | % | 0.0 | % | ||||||||
60.0% – 70.0% | 6.3 | % | 6.3 | % | ||||||||
50.0% – 60.0% | 6.3 | % | 9.4 | % | ||||||||
40.0% – 50.0% | 12.5 | % | 6.3 | % | ||||||||
30.0% – 40.0% | 6.3 | % | 0.0 | % | ||||||||
20.0% – 30.0% | 6.3 | % | 9.4 | % | ||||||||
10.0% – 20.0% | 9.4 | % | 21.9 | % | ||||||||
0.0% – 10.0% | 21.9 | % | 15.6 | % | ||||||||
<0.0% | 25.0 | % | 18.8 | % | ||||||||
100.0 | % | 100.0 | % |
Beneficial Owner | Number of Shares Beneficially Owned(1) | Percentage Beneficially Owned | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Scott D. Dorfman | 5,839,462 | (2) | 44.1 | % | ||||||||
Robert J. Toner | 281,171 | (3) | 2.1 | % | ||||||||
Larry C. Hanger | 226,097 | (3) | 1.7 | % | ||||||||
Christine A. Herren | 40,000 | (4) | * | |||||||||
Bruce V. Benator | 76,000 | (5) | * | |||||||||
James W. Childs | 20,000 | * | ||||||||||
Thomas J. Marano | 75,000 | (5) | * | |||||||||
Joel E. Marks | 105,000 | (6) | * |
2013 | 2014 | 2015 | 2016 | 2017 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(in millions) | |||||||||||||||||||||||||||
Initial Financial Forecast | |||||||||||||||||||||||||||
Revenues | $ | 121.0 | $ | 134.0 | $ | 148.7 | $ | 164.8 | $ | 182.5 | |||||||||||||||||
Cost of revenues | 68.3 | 75.7 | 84.3 | 93.7 | 103.9 | ||||||||||||||||||||||
Operating expenses | 46.6 | 49.3 | 50.8 | 52.9 | 55.1 | ||||||||||||||||||||||
Adjusted EBITDA | 12.2 | 14.6 | 19.3 | 24.5 | 30.1 | ||||||||||||||||||||||
Updated Financial Forecast | |||||||||||||||||||||||||||
Revenues | $ | 127.2 | $ | 143.5 | $ | 159.4 | $ | 176.7 | $ | 195.7 | |||||||||||||||||
Cost of revenues | 71.5 | 80.3 | 89.1 | 98.6 | 109.1 | ||||||||||||||||||||||
Operating expenses | 49.0 | 51.2 | 53.4 | 55.9 | 58.5 | ||||||||||||||||||||||
Adjusted EBITDA(1) | 12.9 | 17.5 | 22.7 | 28.5 | 35.0 |
2013 | 2014 | 2015 | 2016 | 2017 | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(in thousands) | |||||||||||||||||||||||||||
Initial Financial Forecast | |||||||||||||||||||||||||||
Adjusted EBITDA | $ | 12,178 | $ | 14,594 | $ | 19,293 | $ | 24,481 | $ | 30,120 | |||||||||||||||||
Depreciation & amortization | 4,221 | 4,516 | 4,607 | 5,113 | 5,666 | ||||||||||||||||||||||
Public company costs avoided | 467 | 467 | 467 | 467 | 467 | ||||||||||||||||||||||
2013 costs & recurring acquisition savings | 1,359 | 583 | 583 | 583 | 583 | ||||||||||||||||||||||
Interest Expense | 345 | 345 | 345 | 345 | 345 | ||||||||||||||||||||||
Net income | $ | 5,786 | $ | 8,683 | $ | 13,291 | $ | 17,973 | $ | 23,059 | |||||||||||||||||
Updated Financial Forecast | |||||||||||||||||||||||||||
Adjusted EBITDA | $ | 12,923 | $ | 17,483 | $ | 22,692 | $ | 28,474 | $ | 34,981 | |||||||||||||||||
Depreciation & amortization | 3,965 | 4,395 | 4,726 | 5,241 | 5,807 | ||||||||||||||||||||||
Public company costs avoided | 462 | 462 | 462 | 462 | 462 | ||||||||||||||||||||||
2013 costs & recurring acquisition savings | 1,419 | 644 | 644 | 644 | 644 | ||||||||||||||||||||||
Transaction costs expensed in 2013 | 351 | — | — | — | — | ||||||||||||||||||||||
Interest Expense | 304 | 345 | 345 | 345 | 345 | ||||||||||||||||||||||
Net income | $ | 6,422 | $ | 11,637 | $ | 16,515 | $ | 21,782 | $ | 27,723 |
2014 | 2015 | 2016 | 2017 | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
(in thousands) | |||||||||||
$9,247 | $15,976 | $20,025 | $15,857 |
Exhibit No. | Description | ||||
---|---|---|---|---|---|
(a)(1)(A) | Offer to Purchase dated December 4, 2013 (incorporated by reference to Exhibit (a)(1)(A) to the Schedule TO). | ||||
(a)(1)(B) | Letter of Transmittal (incorporated by reference to Exhibit (a)(1)(B) to the Schedule TO). | ||||
(a)(1)(C) | Notice of Guaranteed Delivery (incorporated by reference to Exhibit (a)(1)(C) to the Schedule TO). | ||||
(a)(1)(D) | Letter to Brokers, Dealers, Banks, Trust Companies and Other Nominees (incorporated by reference to Exhibit (a)(1)(D) to the Schedule TO). | ||||
(a)(1)(E) | Letter to Clients for use by Brokers, Dealers, Banks, Trust Companies and Other Nominees (incorporated by reference to Exhibit (a)(1)(E) to the Schedule TO). | ||||
(a)(5)(A) | Press Release issued by Innotrac Corporation on November 14, 2013 (incorporated by reference to the Schedule 14D-9C filed by Innotrac Corporation on November 15, 2013 (one of two)). | ||||
(a)(5)(B) | Letter to Customers from the Chief Executive Officer of Innotrac Corporation, dated November 15, 2013 (incorporated by reference to the Schedule 14D-9C filed by Innotrac Corporation on November 15, 2013 (two of two) (the “Schedule 14D-9C”)). | ||||
(a)(5)(C) | Letter to Employees from the Chief Executive Officer of Innotrac Corporation, dated November 15, 2013 (incorporated by reference to the Schedule 14D-9C). | ||||
(a)(5)(D) | List of Frequently Asked Questions sent to employees of Innotrac Corporation (incorporated by reference to the Schedule 14D-9C). | ||||
(e)(1) | Agreement and Plan of Merger, dated as of November 14, 2013, among Blue Eagle Holdings, L.P., Blue Eagle Acquisition Sub., Inc. and Innotrac Corporation (incorporated by reference to Exhibit 2.1 to the Current Report on Form 8-K filed by Innotrac Corporation on November 15, 2013 (the “Form 8-K”)). | ||||
(e)(2) | Equity Financing Commitment Letter, dated November 14, 2013, from Sterling Capital Partners IV, L.P. to Blue Eagle Holdings, L.P. and Innotrac Corporation (incorporated by reference to Exhibit 2.2 to the Form 8-K). | ||||
(e)(3) | Support Agreement, dated November 14, 2013, between Innotrac Corporation, Mark E. Dottore, as the Court appointed receiver for all assets of any kind of IPOF L.P., IPOF Fund, and IPOF Fund II, L.P., and Blue Eagle Holdings L.P. (incorporated by reference to Exhibit 10.1 to the Form 8-K). | ||||
(e)(4) | Contribution and Support Agreement, dated November 14, 2013, between Blue Eagle Holdings L.P., Scott D. Dorfman and Other Investors Named Therein (incorporated by reference to Exhibit 10.2 to the Form 8-K). | ||||
(e)(5) | Amended and Restated Aircraft Lease, dated November 14, 2013, by and between SDD Holdings, Inc. and Innotrac Corporation (incorporated by reference to Exhibit 10.3 to the Form 8-K). | ||||
(e)(6) | Amended and Restated Employment Agreement dated November 14, 2013 between Innotrac Corporation and Scott D. Dorfman (incorporated by reference to Exhibit 10.4 to the Form 8-K). |
Exhibit No. | Description | ||||
---|---|---|---|---|---|
(e)(7) | Amended and Restated Employment Agreement dated November 14, 2013 between Innotrac Corporation and Robert J. Toner (incorporated by reference to Exhibit 10.5 to the Form 8-K). | ||||
(e)(8) | Amended and Restated Employment Agreement dated November 14, 2013 between Innotrac Corporation and Larry C. Hanger (incorporated by reference to Exhibit 10.6 to the Form 8-K). | ||||
(e)(9) | Employment Agreement dated November 14, 2013 between Innotrac Corporation and Stephen G. Keaveney (incorporated by reference to Exhibit 10.7 to the Form 8-K). | ||||
(e)(10) | Employment Agreement dated November 14, 2013 between Innotrac Corporation and Edgar L. Ringer (incorporated by reference to Exhibit 10.8 to the Form 8-K). | ||||
(e)(11) | Subscription and Support Agreement, dated November 14, 2013, between Blue Eagle Holdings, L.P. and Robert Toner (incorporated by reference to Exhibit 7.07 to the Schedule 13D filed by Blue Eagle Holdings, L.P. and other filing persons on November 25, 2013 (the “Schedule 13D”)). | ||||
(e)(12) | Subscription and Support Agreement, dated November 14, 2013, between Blue Eagle Holdings, L.P. and Larry Hanger (incorporated by reference to Exhibit 7.06 to the Schedule 13D). | ||||
(e)(13) | Confidentiality Agreement dated August 8, 2013 between Sterling Capital Partners IV, L.P. and Innotrac Corporation. | ||||
(e)(14) | Portions of Innotrac Corporation’s Proxy Statement Related to its 2013 Annual Meeting of Shareholders filed on April 29, 2013. |
INNOTRAC CORPORATION | ||||||||
Date: December 4, 2013 | By: | /s/ Stephen G. Keaveney | ||||||
Name: | Stephen G. Keaveney | |||||||
Title: | Chief Financial Officer and Secretary |
The Special Committee of the Board of Directors Innotrac Corporation 6465 East Johns Crossing Johns Creek, Georgia 30097 | November 14, 2013 |
By: | /s/ Jason Bass | ||||
Jason Bass | |||||
Managing Director |
Exhibit (e)(13)
CONFIDENTIALITY AGREEMENT
EXECUTION COPY
Harris Williams & Co. (“HW&Co.”)
1001 Haxall Point, 9th Floor
Richmond, Virginia 23219
Ladies and Gentlemen:
You have agreed to discuss with Sterling Fund Management, LLC (“us” or “we” or “our” or “Sterling”) a negotiated transaction (a “Transaction”) involving Innotrac Corporation (the “Company”). As a condition to such discussions, you and the Company have required that we agree to keep strictly confidential all information conveyed to us in whatever form, whether written or oral, regarding the Company and to refrain from using the same except as provided in this letter agreement (“Agreement”).
This Agreement confirms our agreement with you and the Company to retain in strict confidence all information (written or oral) conveyed to us by you, the Company or your or the Company’s respective Representatives (as defined below) relating to the Company, its business or its Affiliates (as defined below), including all notes, analyses, compilations, forecasts, studies, presentations or other documents furnished to us or any of our Representatives, or prepared by us based on information furnished to us or our Representatives, by you, the Company or your or the Company’s respective Representatives, that contain or reflect such information (the “Confidential Information”), unless such information (i) is already in our possession from a source other than the Company or any of its Representatives, or becomes available to us or our Representatives on a nonconfidential basis from a source other than you, the Company or your or the Company’s respective Representatives, provided in any case that such information is not known by us to be subject to any other obligation of confidentiality or restriction on use pursuant to any contractual, legal, fiduciary or other obligation, or (ii) was or becomes generally available to the public without breach of this Agreement by us or our Representatives. “Representatives” with respect to any person means such person’s Affiliates and such person’s and its Affiliates’ directors, officers, employees and agents (including attorneys, accountants, consultants, lenders and similar advisers) and will be further defined with respect to our Representatives only to the extent that such parties receive Confidential Information. “Affiliates” with respect to any person means other persons who control, are controlled by, or are under common control with, the first person, including parent companies, subsidiaries and sister companies; provided however, that with respect to Sterling Fund Management, LLC, “Affiliates” shall not include portfolio companies of its private equity funds unless such portfolio companies (i) receive Confidential Information or (ii) act at the direction of or with encouragement from Sterling Fund Management, LLC. or any of its other Representatives with respect to any matters contemplated hereby.
We will use the Confidential Information only in connection with our consideration of whether to pursue a Transaction and will not use it for any other purpose whatsoever or disclose it to others, except that we shall have the right to communicate the Confidential Information to such of our Representatives who are required by their duties to have knowledge thereof in order to evaluate the Transaction, provided that each such person is informed that such Confidential Information is strictly confidential and subject to this Agreement and agrees not to disclose or use such Confidential Information except as provided herein. We agree to take all reasonable measures to restrain our Representatives from prohibited or unauthorized disclosure or use of the Confidential Information. We acknowledge and agree that the provision of the Confidential Information does not constitute a license to us or our Representatives to use the Confidential Information for any purpose other than those expressly provided in this Agreement. We hereby agree that we will be liable for any breach of this Agreement by any of our Representatives. Neither we nor our Representatives will disclose the existence of this Agreement, the fact that the Confidential Information has been made available or that discussions or negotiations are taking place concerning a Transaction or any of the terms, conditions or other facts with respect thereto (including the status thereof).
1 of 5 |
We hereby acknowledge that we are aware, and that we will advise our Representatives who are informed as to the matters which are the subject of this Agreement, that U.S. securities laws may prohibit any person who has received from an issuer such as the Company material, non-public information concerning the matters which are the subject of this Agreement from purchasing or selling securities of such issuer or from communicating such information to any other person under circumstances in which it is reasonably foreseeable that such person is likely to purchase or sell such securities.
All of our and our Representatives’ (i) communications regarding a Transaction, (ii) requests for additional information, (iii) requests for facility tours or management meetings and (iv) questions regarding procedure must be directed to you. We will not contact any stockholder, director, officer, employee or agent of the Company or its Affiliates, or any customer, supplier or other person having a business relationship with the Company or its Affiliates, regarding the Company, its Affiliates, the Company’s assets, business, operations, personnel, prospects or finances, the Confidential Information or a Transaction, except with the prior written permission of the Company.
We acknowledge (i) that neither HW&Co., the Company, nor any of their respective Representatives has made or is making, (ii) that the Confidential Information does not constitute, and (iii) that we are not relying on, any representation or warranty, express or implied, regarding the accuracy or completeness of the Confidential Information, including without limitation any projections, estimates, budgets or information relating to the assets, liabilities, results of operations, condition (financial or otherwise), customers, suppliers or employees of the Company, and neither HW&Co., the Company nor any of their Representatives shall have any liability to us or any of our Representatives relating to or resulting from the use of the Confidential Information. The only representations and warranties on which we may rely will be those, if any, expressly set forth in a definitive agreement between the Company and us with respect to a Transaction, and then only to the extent provided in such agreement. We understand that the Company shall have the right in its sole discretion to determine what Confidential Information to make available to us and reserves the right to adopt additional specific procedures to protect the confidentiality of certain sensitive Confidential Information.
The Company may, in its sole discretion, reject any and all proposals made by us or on our behalf with regard to a Transaction and terminate discussions and negotiations with us at any time and for any or no reason. We acknowledge that (i) you and the Company shall conduct the process for a Transaction and you and the Company shall determine the form, manner and timing of all negotiations concerning a Transaction or any transaction with a third party (including, without limitation, negotiating with any prospective buyer and entering into definitive agreements without prior notice to us or any other person), (ii) any procedures relating to a Transaction may be changed at any time without notice to us or any other person, (iii) the Company shall have the right, in its sole discretion, to reject or accept any potential buyer, proposal or offer, and to terminate any discussions and negotiations, at any time and for any or no reason, (iv) neither us nor any of our Representatives shall have any claims whatsoever against the Company or HW&Co. or any of their respective Affiliates or Representatives arising out of or relating to such actions and (v) neither us nor any of our Representatives shall challenge any transaction between the Company and a third party on the ground that any such action or inaction was wrongful, discriminatory, unfair or otherwise violated any duty owed us or any of our Representatives, and we hereby release the Company, HW&Co. and their respective Representatives from any claim arising from the foregoing.
In the event that we or any of our Representatives is requested or required by any governmental authority, to disclose any Confidential Information, we will (to the extent permitted by law or legal ruling) give the Company prompt written notice of such request or requirement so that the Company may seek an appropriate order or other remedy protecting the Confidential Information from disclosure, and we will fully cooperate with the Company (at the Company’s expense) to obtain such protective order or other remedy. In the event that a protective order or other remedy is not obtained or the Company waives its right to seek such an order or other remedy, we (or our Representatives to whom such request is directed) may furnish only that portion of the Confidential Information which we (or such Representatives) are legally required to disclose, provided that (to the extent permitted by law or legal ruling) we give the Company written notice of the information to be disclosed as far in advance of its disclosure as practicable and use our best efforts (at the Company’s expense) to obtain assurances that confidential treatment will be accorded to such information.
2 of 5 |
We agree that unless and until a definitive agreement is executed between us and the Company that the Company has no legal obligation of any kind whatsoever with respect to a Transaction by virtue of this Agreement or otherwise. If we determine not to proceed with a Transaction, we will promptly notify you or the Company of such decision. In that event, or if at any time you or the Company so requests, we agree to return to you or destroy (and certify in writing that we have done so) immediately upon request all Confidential Information together with all copies thereof in our possession or to which we have access, provided however that notwithstanding the foregoing nothing in this Agreement shall require the alteration, modification, deletion or destruction of back-up tapes or other media made in the ordinary course of business, nor restrict us or our Representatives from retaining copies of the Confidential Information for legal archival purposes to evidence compliance with the terms of this Agreement or otherwise for legal compliance or regulatory purposes. Notwithstanding any termination of discussions concerning a Transaction and the retention, return or destruction of the Confidential Information, we and our Representatives will continue to be bound by our obligations of nondisclosure and restrictions on use of the Confidential Information and all of the other obligations hereunder.
For a period of eighteen months from the date of this Agreement, neither we nor our Affiliates will employ, solicit or divert any (i) senior management employee of the Company or (ii) any other Company employee with whom we have non-incidental direct contact and about whom we first become aware during our evaluation of a Transaction without the written consent of the Company, provided that we may engage in general solicitations of employment through advertisements or third party recruiters who are not specifically directed to target such employees of the Company, and provided further that we shall not be restricted from hiring any such employees who respond to any such general solicitation or third party recruiter, or who contact us of their own accord.
We agree that, for a period of one year from the date of this Agreement, neither we nor any of our Affiliates will (and neither we nor they will assist or encourage others to), without the prior written consent of the Company, directly or indirectly: (i) acquire or agree, offer, seek or propose to acquire, or cause to be acquired or borrowed, by purchase, loan or otherwise, ownership (including, without limitation, beneficial ownership as defined in Rule 13d-3 of the Securities Exchange Act of 1934, as amended) of voting securities or direct or indirect rights or options to acquire or vote any voting securities of the Company, any material portion of the assets or businesses of the Company or any subsidiary or any bank debt, claims or other obligations of the Company or its subsidiaries or any rights or options to acquire such ownership (including from a third party); (ii) seek or propose to influence or control the management or policies of the Company or to obtain representation on the Company’s Board of Directors, or solicit, or participate in the solicitation of, any proxies or consents with respect to any securities of the Company, or make any public announcement with respect to any of the foregoing; (iii) make any public announcement with respect to, or submit a proposal for, or offer of (with or without conditions) any extraordinary transaction involving the Company or its voting securities or material assets; (iv) enter into any discussions, negotiations, arrangements or understandings with any third party with respect to any of the foregoing, or otherwise form, join or in any way participate in a “group” (as defined in Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) in connection with any of the foregoing; (v) seek or request permission or participate in any effort to do any of the foregoing or make or seek permission to make any public announcement with respect to the foregoing; or (vi) request the Company or any of its Representatives, publicly or privately, to amend or waive any provision of this paragraph. We will promptly advise the Company of any inquiry or proposal made to us with respect to any of the foregoing. Notwithstanding the foregoing, acquisition of the Company's securities solely for investment purposes in any amounts aggregating less than 1% of outstanding shares shall not be prohibited hereby. Notwithstanding the foregoing, nothing in this paragraph shall limit the ability of either party to make oral or written proposals to the other party regarding a Transaction (up until the time the Company enters into a definitive agreement with respect to a Transaction) so long as public disclosure of any such proposal is not then required by applicable law or requirement of an securities exchange on which the Company’s voting securities are listed and so long as the party making such proposal does not make any public disclosure with respect thereto.
We represent that neither we nor any of our Affiliates has entered into any agreement or understanding with any person with respect to a Transaction . We agree that without the prior written consent of the Company, neither we nor any of our Affiliates will enter into any discussions, negotiations, agreements or understandings with any person with respect to a Transaction . Furthermore, we will not enter into any agreement, arrangement or any other understanding, whether written or oral, with any potential financing source or sources that may reasonably be expected to limit, restrict, restrain, otherwise impair in any manner, directly or indirectly, the ability of such financing source or sources to provide financing or other assistance to any other party in a Transaction.
3 of 5 |
In addition, nothing in this Agreement shall restrict or otherwise limit (i) us from sharing any Confidential Information with any of our Representatives or (ii) any of our Representatives from participating in the evaluation, negotiation or consummation of a Transaction on our behalf, provided we comply with the requirements of this Agreement.
We agree that neither the Company nor you will be obligated to pay any fees on our behalf to any broker, finders, attorneys, advisors or other parties claiming to represent us. Without limiting the generality of the nondisclosure obligations contained herein, it is further understood that we are strictly prohibited by this Agreement from acting as a broker or an agent or otherwise using any of the Confidential Information provided us for the benefit of any third party. In considering a Transaction and reviewing the information, we are acting solely on our own behalf and not as part of a group with any third parties. We will not, directly or indirectly, enter into any agreement, arrangement or understanding, or any discussions that may lead to the same with any person regarding a possible transaction involving the Company.
The Company acknowledges and recognizes that Sterling, its members and Affiliates are engaged in making private equity and venture capital investments and/or holding equity or debt securities in entities (“Portfolio Companies”) which (a) may or may not be competing with, directly or indirectly, the Company, and/or (b) which may involve offering or developing similar or competing technologies, products or services to those offered by the Company (such entities described in subsection (a) or (b), “Competing Companies”); therefore, the Company agrees and recognizes that nothing herein shall prevent, deter, limit or hinder, in any way, Sterling, its members or Affiliates from being involved in, investing in or entering into discussions, relationships or agreements with or concerning Competing Companies. The Company acknowledges and recognizes that Portfolio Companies, their directors, officers, employees, representatives, agents and Affiliates, may be Competing Companies, are not our Representatives hereunder and shall not be subject, directly or indirectly, to the provisions hereof applicable to “Representatives”, unless (i) they receive Confidential Information or (ii) such Portfolio Company or their directors, officers, employees, representatives, agents or Affiliates act at our direction of in breach of any matters contemplated hereby. Furthermore, the Company acknowledges that Sterling employees and professional advisors serve as directors or employees of Portfolio Companies, and such Portfolio Companies will not be deemed to have received Confidential Information or be deemed to be acting at our direction solely due to the dual role of any such employee and professional advisors so long as (i) such employee or professional advisor does not provide any Confidential Information to the other directors, officers, employees or agents of such Portfolio Companies and (ii) such Portfolio Company and its other directors, officers, employees or agents do not act at our direction in breach of any matters contemplated hereby.
We agree that money damages might not be a sufficient remedy for any breach of this Agreement by us or our Representatives and, in addition to all other remedies available under applicable law, the Company shall be entitled to seek specific performance and to injunctive or other equitable relief as a remedy for any such breach. In the event of litigation relating to this Agreement, the non-prevailing party will reimburse the prevailing party for its costs and expenses (including, without limitation, legal fees and expenses) incurred in connection with such litigation.
No amendment, modification or discharge of this Agreement, and no waiver hereunder, shall be valid or binding unless set forth in writing and signed by the Company and us. No failure or delay by a party in exercising any right, power or privilege under this Agreement will operate as a waiver thereof, nor will any single or partial exercise thereof preclude any other or further exercise thereof or the exercise of any right, power or privilege under this Agreement. The undersigned is duly authorized to bind us to this Agreement. The disclosure pursuant to this Agreement of Confidential Information which is protected by attorney-client privilege or confidentiality shall not be deemed to waive such privilege or confidentiality to the fullest extent permitted by law.
This Agreement and any dispute arising hereunder or in connection with the matters contemplated hereby, whether in contract, tort or otherwise, shall be governed in all respects by the internal laws of the State of Georgia, without giving effect to Georgia principles or rules of conflict of laws to the extent such principles or rules would require or permit the application of the laws of another jurisdiction. In the event of any litigation arising hereunder or in connection with the matters contemplated hereby, each party agrees to submit to the non-exclusive jurisdiction of courts of the State of Georgia and of the United States located in the County of Fulton.
4 of 5 |
The obligations under this Agreement will terminate two years from the date hereof, except (i) where otherwise stated as a shorter term and (ii) for Confidential Information which constitutes “trade secrets” under applicable law, with respect to which our obligations of confidentiality and use shall continue without termination.
Acknowledged and agreed to as of the date below written: | ||
STERLING FUND MANAGEMENT, LLC | ||
By: | /s/ M. Avi Epstein | |
Name: M. Avi Epstein | ||
Title: General Counsel | ||
Date: 7-26-13 |
Confirmed and agreed to: | ||
INNOTRAC CORPORATION | ||
By: | /s/ Scott Dorfman | |
Name: Scott Dorfman | ||
Title: CEO/President | ||
Date: 8-9-13 |
5 of 5 |
Exhibit (e)(14)
PORTIONS
OF Innotrac Corporation’s Proxy Statement Related to its 2013
Annual Meeting of Shareholders filed on April 29, 2013
filed Pursuant to the Instruction to Item 1005(d) of Regulation M-A
COMPENSATION OF EXECUTIVE OFFICERS AND DIRECTORS
Summary Compensation Table
The following table sets forth the compensation awarded to, earned by, or paid by the Company during the years ended December 31, 2012 and December 31, 2011 to the Company’s Named Executive Officers.
Name and Principal Position |
Year |
Salary (1) |
Bonus (2) |
Stock |
All Other |
Total |
Scott D. Dorfman Chairman, President and Chief Executive Officer |
2012 2011 |
$426,950 $426,950 |
$170,000 —
|
$ 75,000 $255,000 |
$17,709 $10,061 |
$681,963 $692,011 |
Robert J. Toner Senior Vice President and Chief Operations Officer |
2012 2011 |
$300,000 $300,000 |
$ 95,000 —
|
$ 37,500 $ 42,500 |
$ 2,473 $ 2,521 |
$434,973 $345,021 |
Larry C. Hanger Senior Vice President – Client Services |
2012 2011 |
$236,950 $236,950 |
$ 85,000 —
|
$ 15,000 $ 42,500 |
$ 2,473 $ 2,522 |
$339,423 $281,972 |
____________________
(1) | Base salary paid to officers in fiscal year indicated. |
(2) | Discretionary cash bonus based on performance of Named Executive Officer in 2012 was paid in 2013. No discretionary cash bonus was paid to Named Executive Officers for performance in 2011. |
(3) | Consists of restricted stock awards of 50,000 shares to Mr. Dorfman, 25,000 shares to Mr. Toner and 10,000 shares to Mr. Hanger in August 2012, valued at $1.50 per share of restricted stock, the market price of the Company’s stock on the date of grant. Consists of restricted stock awards of 150,000 shares to Mr. Dorfman and 25,000 to Messrs. Toner and Hanger in June 2011, valued at $1.70 per share of restricted stock, the market price of the Company’s stock on the date of grant. |
(4) | Amounts include payment by the Company of premiums on life insurance policies, payments of an automobile lease and payments by the Company of long term and short term disability insurance. |
Narrative Disclosure to Summary Compensation Table
Overview of Executive Compensation
This narrative addresses the material elements of the Company’s compensation program for Named Executive Officers, including the Company’s compensation objectives and overall philosophy, the compensation process and the administration of the program. It is intended to complement and enhance an understanding of the compensation information presented in the “Summary Compensation Table” and other accompanying tables. In this “Narrative Disclosure to Summary Compensation Table” section, the terms “we,” “our,” “us” and the “Committee” refer to the Compensation Committee of the Company’s Board.
Compensation Objectives and Overall Philosophy
The Company’s executive compensation program is designed to enhance Company profitability, and thus shareholder value, by aligning executive compensation with the Company’s business goals and performance, and by attracting, retaining and rewarding executive officers who contribute to the long-term success of the Company. More specifically, the goals of the executive compensation program include:
1 of 9 |
· | offering market competitive total compensation opportunities to attract and retain talented executives; |
· | providing strong links between Company performance and total compensation earned – i.e., paying for performance; |
· | emphasizing long-term performance of the Company, thus enhancing shareholder value; and |
· | promoting and facilitating executive officer stock ownership. |
We believe that it is in the best interests of the Company’s shareholders and its Named Executive Officers that the Company’s executive compensation program, and each of its elements, remains simple and straightforward. This approach should reduce the time and cost involved in setting the Company’s executive compensation policies and calculating the payments under such policies, and should enhance the transparency of, and the ability to comprehend, these policies.
Administration
The Compensation Committee has overall responsibility with respect to approving and monitoring the Company’s executive compensation program, and operates under a Charter that was approved by the Company’s Board in 2004. None of the members of the Compensation Committee has been an officer or employee of the Company, and the Board has considered and determined that all of the members are “independent” as defined under applicable Nasdaq rules and otherwise meet the criteria set forth in the Committee’s Charter.
In fulfilling its responsibilities, the Compensation Committee, among other things, considers and approves the compensation level of each of the Named Executive Officers, reviews and considers corporate goals and objectives relevant to the compensation of the Named Executive Officers, evaluates the performance of the Named Executive Officers in light of these goals and objectives, reviews and approves compensation based on these objectives and its evaluations, reviews criteria for making equity grants to the Named Executive Officers and the Company’s other employees, considering the recommendations of senior management, and approves such equity grants.
We regularly review and discuss the compensation of the Named Executive Officers with Scott D. Dorfman, the Company’s Chairman, President and Chief Executive Officer, and consult with Mr. Dorfman in evaluating the performance of the Named Executive Officers. In addition, Mr. Dorfman may make recommendations to us regarding compensation for all of the Named Executive Officers.
As discussed in greater detail below, the levels of each element of compensation for the Named Executive Officers are determined based on several factors, which may include the Company’s performance and relative shareholder return, informal benchmarking against the value of similar compensation to executives at comparable companies, compensation provided in previous years, the terms of each Named Executive Officer’s employment agreement with the Company, if such an agreement has been entered into, and other matters that we deem relevant. In addition, we consider the level of experience and the responsibilities of each Named Executive Officer, his performance as well as the personal contributions he makes to the success of the Company. Qualitative factors such as leadership skills, analytical skills and organizational development have been and will continue to be deemed to be important qualitative factors to take into account in considering elements and levels of compensation. We have not adopted any formal or informal policy for allocating compensation between long-term and short-term, between cash and non-cash or among the different possible forms of non-cash compensation.
The Company’s executive compensation program consists of two primary elements, base salary and annual discretionary performance bonuses. In 2012, performance bonuses took the form of cash awards and restricted stock and in 2011 performance bonuses took the form of restricted stock. In addition to these primary elements, the Company has provided, and will continue to provide, its Named Executive Officers with certain benefits, such as healthcare plans, that are available to all employees.
2 of 9 |
Elements of Compensation
Base Salary. On an annual basis we determine the base salary for each of the Named Executive Officers. The base salary for a Named Executive Officer is established based on, among other things, his experience and the scope of his responsibilities, his performance and the performance of the Company and our informal benchmarking against the value of similar salaries paid to executives at comparable companies. The minimum levels of some of these base salaries are mandated by employment agreements with the Named Executive Officers (which are described in more detail below under the heading “Employment Agreements with Named Executive Officers”). We believe that base salaries are an important part of the Company’s executive compensation program because they provide the Named Executive Officers with a steady income stream that is not contingent upon the Company’s overall performance.
Mr. Dorfman has an employment agreement with the Company which renews for an additional 12 month term each December 31st providing certain conditions are met and provides for a minimum annual base salary of $425,000. Messrs. Toner and Hanger have employment agreements with the Company with an expiration date of December 31, 2015. Under these agreements, the minimum base salary is set at an amount not materially different than their respective 2012 salaries disclosed in the “Summary Compensation Table.”
Annual Discretionary Bonuses. We utilize annual discretionary bonuses, in the form of cash and equity awards, to reward the Named Executive Officers for their performance and the performance of the Company during the prior year. We have not adopted any formal or informal performance objectives for the calculation or payment of these discretionary bonuses. Instead, in determining an annual discretionary bonus, we consider, among other things, the Company’s performance during the prior year, relative shareholder value, discretionary bonuses awarded in previous years, the performance of the Named Executive Officer and his personal contributions to the success of the Company.
Annual discretionary cash bonuses, as opposed to equity-based awards, are designed to more immediately reward the Named Executive Officers for their performance. The immediacy of these bonuses provides a significant incentive to the Named Executive Officers to raise their level of performance, and thus the Company’s overall level of performance. Thus, we believe that discretionary cash bonuses can be an important motivating factor for the Named Executive Officers.
We approved the payment of cash bonuses to Messrs. Dorfman, Toner and Hanger in 2013 based on their level of performance in 2012 in the amounts set forth in the “Summary Compensation Table.” There were no discretionary cash bonuses paid in 2012 for 2011 performance.
Restricted stock and other equity-based awards provide the Named Executive Officers with a strong link to the Company’s long-term performance, promote an ownership culture, and more closely align the interests of the Named Executive Officers and the Company’s shareholders. In March 2013, we approved and issued equity-based awards in the amounts of 100,000 shares to Mr. Dorfman, 25,000 shares to Mr. Toner and 10,000 shares to Mr. Hanger for the year 2012. In March 2012, we approved and in August 2012 we issued equity-based awards in the form of restricted stock in the amounts of 50,000 shares to Mr. Dorfman, 25,000 shares to Mr. Toner and 10,000 shares to Mr. Hanger for the year 2011. In June 2011, we approved equity-based awards in the form of restricted common stock in the amounts of 150,000 shares to Mr. Dorfman and 25,000 for Messrs. Toner and Hanger for the year 2010. Under the terms of the awards, the restricted shares are held by the company until they vest at a rate of twenty-five percent (25%) on each of the 7th, 8th, 9th and 10th anniversary of June 10, 2011. If a Named Executive Officer’s employment with the Company discontinues for any reason before some restricted shares are vested, the unvested restricted shares are forfeited.
In the future, equity incentive awards can be granted under the Company’s 2010 Innotrac Stock Award Plan (the “2010 Plan”) which was approved at the June 2, 2010 annual shareholder meeting. The 2010 plan, as did the Company’s 2000 Stock Option and Incentive Award Plan (the “2000 Plan”) which expired on March 28, 2010, provides the Company with broad discretion to fashion the terms of awards to provide eligible participants with such stock-based incentives as we deem appropriate. It permits the issuance of awards in a variety of forms, including non-qualified stock options and incentive stock options, stock appreciation rights, stock awards, restricted stock awards and performance shares. Vesting terms for equity incentive awards are determined on a case by case basis.
3 of 9 |
Severance and Change of Control Arrangements. As discussed in more detail in the “Employment Agreements with Named Executive Officers” and “Potential Payments Upon Termination or Change in Control” sections below, the Named Executive Officers may be entitled to certain benefits upon the termination of their respective employment or change in control agreements.
Other Compensation. The Named Executive Officers currently are entitled to participate in the Company’s group medical, vision and dental coverage, group life insurance and group long-term disability insurance plans and in our 401(k) plan to the same extent that the Company’s employees are entitled to participate. In addition, Named Executive Officers can participate in a deferred compensation plan with respect to which Innotrac may provide matching contributions. All Company matches permitted under the executive deferred compensation plan have been suspended.
A summary of certain other material terms of the Company’s compensation plans and arrangements is set forth below.
Employment Agreements with Named Executive Officers
Scott D. Dorfman. Mr. Dorfman entered into a new agreement to serve as Innotrac’s Chairman of the Board, President and Chief Executive Officer on April 16, 2007. The initial term of the new agreement expired on December 31, 2009 and automatically extends until each December 31st thereafter, unless either the Company or Mr. Dorfman provides written notice of non-renewal to the other party no later than the September 30th prior to the upcoming December 31st expiration date. Mr. Dorfman is entitled to a salary of no less than $425,000 per year and is eligible for annual increases and a performance-based bonus. He may participate in such benefit plans as Innotrac maintains from time to time for senior executives, and receives customary perquisites.
Mr. Dorfman’s employment agreement may be terminated by either party if he dies or becomes disabled, by Innotrac for “good cause” (as defined in the agreement) or for any reason by either party upon 90 days’ notice. If the Company terminates Mr. Dorfman’s employment without “good cause”, he is entitled to receive a pro rata portion of his bonus for the year in which the termination occurs, based upon the year to date financials and performance of the Company and assuming performance at the target level for any individual performance criteria. If the Company terminates Mr. Dorfman’s employment other than for “good cause” or due to his death or total disability, he is entitled to receive severance pay equal to his base salary for six months following such termination, and all unvested Company stock options will immediately become fully vested and exercisable upon such termination. If Mr. Dorfman’s employment is terminated by the Company for “good cause”, all unvested Company stock options will be forfeited as of the termination date.
Mr. Dorfman’s employment agreement also provides for Mr. Dorfman to receive certain benefits if his employment is terminated within 18 months following the date of a “Change in Control.” The agreement defines a “Change in Control” as any of the following: (i) the acquisition (other than from the Company) by any person of beneficial ownership of 50% or more of the combined voting power of the Company’s then outstanding voting securities; (ii) consummation of (1) a merger or consolidation involving the Company if the shareholders of the Company, immediately before such merger or consolidation do not, as a result of such merger or consolidation, own, directly or indirectly, more than 50% of the combined voting power of the then outstanding voting securities of the corporation resulting from such merger or consolidation in substantially the same proportion as their ownership of the combined voting power of the voting securities of the Employer outstanding immediately before such merger or consolidation, or (2) a complete liquidation or dissolution of the Company, or (3) an agreement for the sale or other disposition of all or substantially all of the assets of the Company; (iii) a change in the composition of the Company’s Board such that the individuals who, as of the date of the agreement, constitute the board cease for any reason to constitute at least a majority of the board; (iv) the occurrence of any other event or circumstance which is not covered by (i) through (iii) above which the board determines affects control of the Company and adopts a resolution that such event or circumstance constitutes a Change in Control for the purposes of the agreement. The Agreement also defines “good reason” for which Mr. Dorfman may resign following a change of control as: (i) the assignment to Mr. Dorfman of any duties inconsistent with his title and status, or a substantial adverse alteration in the nature or status of his responsibilities at the Company from those in effect immediately prior to the Change in Control; (ii) a substantial reduction by the Company in Mr. Dorfman’s base salary; (iii) the relocation of Mr. Dorfman’s principal office to a place more than 50 miles from Atlanta, Georgia; (iv) the failure by the Company to
4 of 9 |
continue in effect any compensation or benefit plan or program in which Mr. Dorfman participates immediately prior to the change in control, which is material to Mr. Dorfman’s total compensation, unless an equitable arrangement has been made with respect to such plan, or the failure by the Company to continue Mr. Dorfman’s participation in such plan on a basis not materially less favorable.
If there is a Change in Control of the Company and Mr. Dorfman’s employment is terminated by the Company other than for “good cause” or due to his death or total disability or by Mr. Dorfman for “good reason” within 18 months following the date of the Change in Control, then, in addition to any accrued salary payable, but in lieu of the above-described severance payments, Mr. Dorfman is entitled to receive severance payments in the amount of his salary as then in effect for a period of 18 months from his date of termination, and all outstanding Company stock options will become fully vested on the date of termination. If Mr. Dorfman terminates his employment within 18 months following the date of the Change in Control other than for “good reason”, he will be entitled to receive the same compensation and benefits described immediately above, but with a severance period of 12 months rather than 18 months.
Mr. Dorfman is subject to customary confidentiality, noncompetition and nonsolicitation covenants during the term of his employment and for an additional period following his termination. The post-termination noncompetition and nonsolicitation period is 12 months.
All payments and benefits under the employment agreement are subject to compliance with the requirements of Section 409A of the Internal Revenue Code.
Robert J. Toner and Larry C. Hanger. Messrs. Toner and Hanger each have employment agreements with the Company which provide that they will serve in their respective positions and have minimum salaries materially the same as they received in 2011 and as presented in the compensation chart above. These agreements expire on December 31, 2015 and automatically extend to the next December 31st thereafter, unless either the Company or the executive provides written notice of non-renewal to the other party no later than the September 30th prior to the upcoming December 31st expiration date. Each executive is eligible for annual increases and a performance-based bonus. The other provisions of these executive’s employment agreements are similar to those described above with respect to Mr. Dorfman’s employment agreement, with the following exceptions: (1) the severance payments to which these executives are entitled upon termination by the Company other than for “good cause” or due to his death or total disability is equal to six months of salary, and (2) the post-termination noncompetition and nonsolicitation period will be 12 months.
2000 Stock Option and Incentive Award Plan and the Innotrac 2010 Stock Award Plan
The Company’s shareholder-approved 2000 Stock Option and Incentive Award Plan expired on March 28, 2010. On March 29, 2010 the Board approved and on June 2, 2010, the Company’s shareholders ratified the 2010 Plan replacing the 2000 Plan. The 2010 Plan is a flexible plan that provides the Compensation Committee with broad discretion to fashion the terms of awards to provide eligible participants with such equity-based incentives as the Committee deems appropriate. It permits the issuance of awards in a variety of forms, including non-qualified stock options and incentive stock options, stock appreciation rights, stock awards, restricted stock awards and performance shares.
Benefits
The Named Executive Officers also participate, on a voluntary basis, in Innotrac’s regular employee benefit programs, including group medical, vision and dental coverage, group life insurance and group long-term disability insurance and in Innotrac’s 401(k) plan. In addition, Named Executive Officers can participate in a deferred compensation plan with respect to which Innotrac may provide matching contributions. All Company matches permitted under the executive deferred compensation plan have been suspended.
Outstanding Equity Awards at Fiscal Year-End
The following table provides information on the current holdings of stock options and stock awards by the Named Executive Officers, including both unexercised and unvested awards. The market value of the stock awards
5 of 9 |
is based upon the closing market price for the Company’s Common Stock as of December 31, 2012, the last trading day in 2012, which was $3.05.
Stock Awards |
Option Awards | ||||||
Name |
Stock Award Date |
Number of shares or units of stock that have not vested |
Market value of shares or units of stock that have not vested |
Option Grant Date |
Number of Securities Underlying Unexercised Options Exercisable |
Option Exercise Price |
Option Expiration Date |
Scott D. Dorfman |
08/31/2012 06/09/2011 03/29/2010 |
50,000(1) 150,000(2) 50,000(3) |
$152,500 $457,500 $152,500 |
— | — | — | — |
Robert J. Toner |
08/31/2012 06/09/2011 03/29/2010 |
25,000(1) 25,000(2) 50,000(3) |
$ 76,250 $ 76,250 $152,500 |
08/15/2005 | 50,000 | $4.56 | 08/15/2015 |
04/16/2007 | 88,652(4) | $270,389 | |||||
Larry C. Hanger |
08/31/2013 06/09/2011 03/29/2010 |
10,000(1) 25,000(2) 25,000(3) |
$ 30,500 $ 76,250 $ 76,250 |
08/15/2005 | 50,000 | $4.56 | 08/15/2015 |
04/16/2007 | 88,652(4) | $270,389 | |||||
(1) | On August 31, 2012, 50,000 shares of restricted shares were issued to Mr. Dorfman, 25,000 restricted shares were to Mr. Toner and 10,000 restricted shares were issued to Mr. Hanger under the terms provided in the 2010 Plan. The market price of our stock on the date of issuance of the restricted shares was $1.50 and they vest in equal amounts on the 7th, 8th, 9th and 10th anniversary dates of their issuance, subject to accelerated vesting in the event of a change in control of the Company. |
(2) | On June 10, 2011, 150,000 restricted shares were issued to Mr. Dorfman and 25,000 restricted shares were issued to each of Messrs. Toner and Hanger under the terms provided in the 2010 Plan. The market price of our stock on the date of issuance of the restricted shares was $1.70 and they vest in equal amounts on the 7th, 8th, 9th and 10th anniversary dates of their issuance, subject to accelerated vesting in the event of a change in control of the Company |
(3) | On March 29, 2010, 50,000 restricted shares were issued to each of Messrs. Dorfman and Toner and 25,000 restricted shares were issued to Mr. Hanger under the terms provided in the 2010 Plan. The market price of our stock on the date of issuance of the restricted shares was $1.64 and they vest in equal amounts on the 7th, 8th, 9th and 10th anniversary dates of their issuance, subject to accelerated vesting in the event of a change in control of the Company. |
(4) | On April 16, 2007, 88,652 restricted shares were issued to each of Messrs. Toner and Hanger under the terms provided in the Executive Retention Plan. The Executive Retention Plan was subsequently terminated in early 2010, however the restricted shares remain issued. The market price of our stock on the date of issuance of the restricted shares was $2.82 and they vest in equal amounts on the 7th, 8th, 9th and 10th anniversary dates of their issuance, subject to accelerated vesting in the event of a change in control of the Company. |
6 of 9 |
Potential Payments Upon Termination or Change in Control
The Company is party to employment agreements with certain of its Named Executive Officers. These employment agreements address, among other things, compensation and benefits that would be paid to the Named Executive Officers in the event that his employment is terminated for different reasons, including termination for cause or without cause, and termination in connection with a change in control. See above under the headings “Employment Agreements with Named Executive Officers” for a complete discussion of the terms of these employment agreements.
In addition, the Company’s equity-based incentive plan and the award agreements under that plan, as modified by the employment agreements discussed above, call for compensation to be provided and vesting to be accelerated under certain circumstances in connection with the termination of a Named Executive Officer’s employment or a change in control of the Company.
Non-Employee Director Compensation
The current compensation program for the Company’s non-employee directors is designed to pay directors for work required for a company of Innotrac’s size and scope and to align the directors’ interests with the long-term interests of Company’s shareholders.
Non-employee directors receive annual compensation of $20,000 as compensation for service on the Board. Beginning in June, 2011, non-employee directors receive an annual grant, providing they served as a member in good standing for the full year prior to the annual grant, of 10,000 restricted shares. The vesting period of the annual grant is 1/3rd (3,333 shares) at grant date, 1/3rd (3,333 shares) on the 1st anniversary of the grant date and the final 3,334 shares on the 2nd anniversary of the grant date provided the director served as a member in good standing for the full year prior to the 1st and 2nd anniversary the annual grant, and subject to accelerated vesting in the event of a change in control of the Company. Additionally, each non-employee director receives a cash payment of $250 for each Board meeting that he attends and a cash payment of $100 for each committee meeting that he attends.
The members of the Board who are employees of the Company do not receive additional compensation for Board or committee service.
The following table provides information on compensation paid to non-employee directors in 2012.
Name |
Grant of Restricted Shares (5) |
Fees Earned or Paid in Cash |
Total |
Bruce V. Benator (1) | $ 15,000 | $ 21,950 | $ 36,950 |
Thomas J. Marano (2) | $ 15,000 | $ 21,950 | $ 36,950 |
Joel E. Marks (3) | $ 15,000 | $ 21,950 | $ 36,950 |
James W. Childs (4) | $ 15,000 | $ 19,100 | $ 34,100 |
____________________
(1) | Member of the Nominating/Governance Committee of the Board. |
(2) | Member of the Audit and Nominating/Governance Committees of the Board. |
(3) | Member of the Audit, Compensation and Nominating Governance Committees of the Board. |
(4) | Member of the Audit and Compensation Committees of the Board. |
(5) | Each Director received a Grant of 10,000 restricted shares of stock on August 31, 2012 at a market value of $1.50 per share. The restricted shares vest at a rate of 1/4th on each of the 7th, 8th, 9th and 10th anniversaries of the grant date (or earlier upon a change in control), unless the Director’s service with the Company terminates other than the removal of the Director for cause prior to all shares vesting, in which case shares vest 1/3rd on the grant date and 1/3rd on each of the 1st and 2nd anniversaries of the grant date. |
7 of 9 |
Compensation Committee Interlocks and Insider Participation
During 2012, the Compensation Committee was comprised of Messrs. Childs and Marks, both of whom were non-employee, independent directors. No interlocking relationship exists between our Board, Compensation Committee or executive officers and the board of directors, compensation committee or executive officers of another company.
RELATED PERSON TRANSACTIONS
Policy on Related Person Transactions
The Company recognizes that transactions between the Company or its subsidiaries and any of its directors or executive officers can present potential or actual conflicts of interest. Accordingly, as a general matter it is the Company’s preference to avoid such transactions. Nevertheless, the Company recognizes that there are circumstances where such transactions may be in, or not inconsistent with, the best interests of the Company. Therefore, the Company has adopted a formal policy that requires the Company’s Audit Committee to review and, if appropriate, approve or ratify any such transactions. Pursuant to the policy, the Committee will review any transaction in which the Company is or will be a participant, and in which any of the Company’s directors, executive officers or 5% shareholders had, has or will have a direct or indirect material interest. After its review, the Committee will only approve or ratify those transactions that are in, or are not inconsistent with, the best interests of the Company and its shareholders.
Certain Related Person Transactions
The Company leases a single engine aircraft from a company wholly-owned by its Chairman and Chief Executive Officer. The Company pays a pro-rated amount of the maintenance, insurance, taxes, fuel and other expenses associated with the aircraft based on Innotrac’s business use of the aircraft, which was approximately 86% for both 2012 and 2011. This allocation is reviewed by the Audit Committee annually. Innotrac paid approximately $224,000 for Innotrac’s use of the aircraft in 2012 and $201,000 for its use of the aircraft in 2011. In August 2012, the Company made $367,000 in improvements to the aircraft which will be depreciated over the ten year term of the lease. Under the terms of the airplane lease between the Company and the Chairman and Chief Executive Officer, i) should the airplane not be made available for use as required by the Company, the Chief Executive Officer will reimburse the Company for the undepreciated portion of the improvements, and ii) if the Company should cancel the lease of the aircraft before its contract term ending in August 2022, the Company would not require the Chief Executive to reimburse the Company for the undepreciated portion of the improvements.
As of December 31, 2012, IPOF Fund, L.P. and its affiliates (the “IPOF Group”) held approximately 32.9% of the outstanding common stock of the Company. Pursuant to an order dated November 21, 2005, the United States District Court in Cleveland, Ohio has appointed a receiver to identify and administer the assets of the IPOF Fund, L.P. and its general partner, Mr. David Dadante. Based on information from the receiver, the Company understands that the Fund and Mr. Dadante own 4,321,771 shares of common stock of the Company, representing approximately 32.9% of the total shares outstanding, all of which are held as collateral in margin accounts maintained at several financial institutions. On February 23, 2011, the court extended a previous order prohibiting the financial institutions holding Company stock owned by the IPOF Fund and Mr. Dadante in margin accounts from selling any of these shares for an indefinite period. The court has permitted open market sales by the receiver as he may in his sole discretion determine to be consistent with his duty to maximize the value of the assets of IPOF Fund, and as warranted by market conditions. The receiver has indicated to the Company that he does not intend to direct any open market sales during this period except in circumstances in which he believes that there would be no material adverse impact on the market price for the Company’s shares. Nevertheless, as long as these shares are held in margin accounts where the lenders desire to liquidate the positions, there will be significant downward pressure on the market price of our common stock because the market is concerned that these shares may be sold in a manner that causes the price of our common stock to decline precipitously. This concern is ameliorated to some degree by the indefinite prohibition by the court on sales of our shares by financial institutions that hold the shares in
8 of 9 |
margin accounts. The Company continues to engage in discussions from time to time with the receiver in an effort to cause the shares to be sold in a manner that causes as little disruption to the market for Company stock as possible. If the court were to issue a new order discontinuing this prohibition before the shares have been sold in such a transaction, then the financial institutions might foreclose on some or all of these shares and sell them into the market, which could have an extremely negative impact on the market price for our common stock.
9 of 9 |